OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production utilizes Chinese hamster ovary (CHO) cells due to their robustness in expressing complex biologics. Optimizing these processes involves adjusting various factors, including cell line development, media formulation, and bioreactor conditions. A key goal is to maximize antibody titer while lowering production financial